Gluten ID analyzes variants associated with two genes (HLA-DQA1 and HLA-DQB1) to identify haplotypes (Gluten IDs) known to fall within a spectrum of risk for celiac disease. If none of the risk Gluten IDs are detected, the test is interpreted as non-celiac genetics (NCG.)
Typical celiac related symptoms include bloating/gas, diarrhea, fatigue, skin rashes, anemia, delayed growth, weight loss.
For more information on symptoms, facts, and history visit the page below:
To view instructions on sample collection, please visit the page below:
To know more about the test, please visit the page below:
About the Test
The GlutenID test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from buccal (cheek) cells for the purpose of reporting and interpreting celiac genetic health risk (GHR). This test is not intended to diagnose celiac disease. Your ethnicity may affect the relevance of the report and how your celiac genetic health risk results are interpreted. The variants included in this report are supported by Level 1 (the highest) level of evidence. The celiac risk variants are most common in people of northern European descent. The celiac GHR report describes if a person has variants associated with a higher risk of developing celiac disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations: This report does not include variants in other genes linked to celiac disease and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact celiac risk. The GlutenID test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. The intended use of the GlutenID Test does not include prenatal testing, cancer predisposition, pharmacogenomic assessment, or determination of autosomal dominant genetic variants. For important information and limitations regarding genetic health risk reports, visit Targeted-Genomics.com/about-the-test/
The American College of Gastroenterology recommends HLA-DQ2/DQ8 testing to identify at-risk first degree relatives in celiac disease families and to effectively rule out celiac disease when testing is negative for DQ2/DQ8 genes.
We encourage you to consult with a genetic counselor, a healthcare provider with special training in genetic conditions which run in families like celiac disease . A genetics counselor will be able to answer your questions and help you and your family make informed diet and lifestyle choices. We recommend you consult with a counselor before and after testing so you can better understand risks and benefits of genetic testing. Your genetics counselor can also help you understand your test results. Ask your doctor to refer you to a genetic counselor or click here.
The only treatment for celiac disease is to follow a strict life-long gluten-free diet. This means avoiding foods and beverages containing gluten, a protein found in wheat, rye, and barley.